Investigation of the fate of type I angiotensin receptor after biased activation

Molecular Pharmacology

Volumn 87, Issue 6, 2015, Pages 972-981

  Szakadáti, Gyöngyi ^a   Tóth, András D ^a   Oláh, Ilona ^a   Erdélyi, László Sándor ^a   Balla, Tamas ^b   Várnai, Péter ^a   Hunyady, László ^a   Balla, András ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; BETA ARRESTIN; BETA ARRESTIN 2; GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; RAB PROTEIN; RAB11 PROTEIN; RAB7 PROTEIN; RENILLA LUCIFERIN 2 MONOOXYGENASE; TYPE I ANGIOTENSIN RECEPTOR; UNCLASSIFIED DRUG; YELLOW FLUORESCENT PROTEIN; ANGIOTENSIN 1 RECEPTOR; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; LIGAND; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE; PHOSPHATIDYLINOSITOL KINASE; RETINA S ANTIGEN;

ARTICLE; BINDING AFFINITY; BINDING KINETICS; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CELL CULTURE; CELL FATE; CELL MEMBRANE; CELL MIGRATION; CELL STIMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTERNALIZATION; INTRACELLULAR SIGNALING; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN STABILITY; RECEPTOR BINDING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WILD TYPE; AGONISTS; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; GENETICS; HEK293 CELL LINE; HYDROLYSIS; METABOLISM;

1-PHOSPHATIDYLINOSITOL 4-KINASE; ANGIOTENSIN II; ARRESTINS; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER TECHNIQUES; CELL MEMBRANE; ENDOCYTOSIS; GREEN FLUORESCENT PROTEINS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HEK293 CELLS; HUMANS; HYDROLYSIS; LIGANDS; LUCIFERASES, RENILLA; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE; PHOSPHOINOSITIDE PHOSPHOLIPASE C; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 84940069288     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.114.097030     Document Type: Article

References (51)

1. Anborgh PH, Seachrist JL, Dale LB, and Ferguson SS (2000) Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors. Mol Endocrinol 14:2040-2053.
2. Balla A and Balla T (2006) Phosphatidylinositol 4-kinases: old enzymes with emerging functions. Trends Cell Biol 16:351-361.
3. Balla A, Kim YJ, Varnai P, Szentpetery Z, Knight Z, Shokat KM, and Balla T (2008) Maintenance of hormone-sensitive phosphoinositide pools in the plasma membrane requires phosphatidylinositol 4-kinase IIIalpha. Mol Biol Cell 19:711-721.
4. Balla A, Tóth DJ, Soltész-Katona E, Szakadáti G, Erdélyi LS, Várnai P, and Hunyady L (2012) Mapping of the localization of type 1 angiotensin receptor in membrane microdomains using bioluminescence resonance energy transfer-based sensors. J Biol Chem 287:9090-9099.
5. Balla A, Tuymetova G, Tsiomenko A, Várnai P, and Balla T (2005) A plasma membrane pool of phosphatidylinositol 4-phosphate is generated by phosphatidylinositol 4-kinase type-III alpha: studies with the PH domains of the oxysterol binding protein and FAPP1. Mol Biol Cell 16:1282-1295.
6. Balla T (2013) Phosphoinositides: tiny lipids with giant impact on cell regulation. Physiol Rev 93:1019-1137.
7. Bojjireddy N, Botyanszki J, Hammond G, Creech D, Peterson R, Kemp DC, Snead M, Brown R, Morrison A, and Wilson S et al. (2014) Pharmacological and genetic targeting of the PI4KA enzyme reveals its important role in maintaining plasma membrane phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate levels. J Biol Chem 289:6120-6132.
8. Bonde MM, Hansen JT, Sanni SJ, Haunsø S, Gammeltoft S, Lyngsø C, and Hansen JL (2010) Biased signaling of the angiotensin II type 1 receptor can be mediated through distinct mechanisms. PLoS ONE 5:e14135.
9. Bucci C, Thomsen P, Nicoziani P, McCarthy J, and van Deurs B (2000) Rab7: a key to lysosome biogenesis. Mol Biol Cell 11:467-480.
10. Carman CV, Parent JL, Day PW, Pronin AN, Sternweis PM, Wedegaertner PB, Gilman AG, Benovic JL, and Kozasa T (1999) Selective regulation of Galpha(q/11) by an RGS domain in the G protein-coupled receptor kinase, GRK2. J Biol Chem 274:34483-34492.
11. Dale LB, Seachrist JL, Babwah AV, and Ferguson SS (2004) Regulation of angiotensin II type 1A receptor intracellular retention, degradation, and recycling by Rab5, Rab7, and Rab11 GTPases. J Biol Chem 279:13110-13118.
12. Danser AH (2003) Local renin-angiotensin systems: the unanswered questions. Int J Biochem Cell Biol 35:759-768.
13. Ferguson SS (2001) Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 53:1-24.
14. Ferguson SS, Ménard L, Barak LS, Koch WJ, Colapietro AM, and Caron MG (1995) Role of phosphorylation in agonist-promoted beta 2-adrenergic receptor sequestration. Rescue of a sequestration-defective mutant receptor by beta ARK1. J Biol Chem 270:24782-24789.
15. Gáborik Z, Jagadeesh G, Zhang M, Spät A, Catt KJ, and Hunyady L (2003) The role of a conserved region of the second intracellular loop in AT1 angiotensin receptor activation and signaling. Endocrinology 144:2220-2228.
16. Gáborik Z, Szaszák M, Szidonya L, Balla B, Paku S, Catt KJ, Clark AJ, and Hunyady L (2001) Beta-arrestin- and dynamin-dependent endocytosis of the AT1 angiotensin receptor. Mol Pharmacol 59:239-247.
17. Godin CM and Ferguson SS (2012) Biased agonism of the angiotensin II type 1 receptor. Mini Rev Med Chem 12:812-816.
18. Hansen JL, Aplin M, Hansen JT, Christensen GL, Bonde MM, Schneider M, HaunsøS, Schiffer HH, Burstein ES, and Weiner DM et al. (2008) The human angiotensin AT(1) receptor supports G protein-independent extracellular signal-regulated kinase 1/2 activation and cellular proliferation. Eur J Pharmacol 590:255-263.
19. Heuser JE and Anderson RG (1989) Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J Cell Biol 108:389-400.
20. Holloway AC, Qian H, Pipolo L, Ziogas J, Miura S, Karnik S, Southwell BR, Lew MJ, and Thomas WG (2002) Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors. Mol Pharmacol 61:768-777.
21. Hunyady L, Baukal AJ, Gaborik Z, Olivares-Reyes JA, Bor M, Szaszak M, Lodge R, Catt KJ, and Balla T (2002) Differential PI 3-kinase dependence of early and late phases of recycling of the internalized AT1 angiotensin receptor. J Cell Biol 157:1211-1222.
22. Hunyady L and Catt KJ (2006) Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol 20:953-970.
23. Hunyady L, Catt KJ, Clark AJ, and Gáborik Z (2000) Mechanisms and functions of AT(1) angiotensin receptor internalization. Regul Pept 91:29-44.
24. Kim J, Ahn S, Ren XR, Whalen EJ, Reiter E, Wei H, and Lefkowitz RJ (2005) Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling. Proc Natl Acad Sci USA 102:1442-1447.
25. Kim KS, Abraham D, Williams B, Violin JD, Mao L, and Rockman HA (2012) β-Arrestin-biased AT1R stimulation promotes cell survival during acute cardiac injury. Am J Physiol Heart Circ Physiol 303:H1001-H1010.
26. Le MT, Vanderheyden PM, Szaszák M, Hunyady L, and Vauquelin G (2002) Angiotensin IV is a potent agonist for constitutive active human AT1 receptors. Distinct roles of the N-and C-terminal residues of angiotensin II during AT1 receptor activation. J Biol Chem 277:23107-23110.
27. Lefkowitz RJ (2007) Seven transmembrane receptors: something old, something new. Acta Physiol (Oxf) 190:9-19.
28. Li H, Li HF, Felder RA, Periasamy A, and Jose PA (2008) Rab4 and Rab11 coordinately regulate the recycling of angiotensin II type I receptor as demonstrated by fluorescence resonance energy transfer microscopy. J Biomed Opt 13:031206.
29. Luttrell LM, Roudabush FL, Choy EW, Miller WE, Field ME, Pierce KL, and Lefkowitz RJ (2001) Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc Natl Acad Sci USA 98:2449-2454.
30. Maxfield FR and McGraw TE (2004) Endocytic recycling. Nat Rev Mol Cell Biol 5:121-132.
31. Orlandi PA and Fishman PH (1998) Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol 141:905-915.
32. Qian H, Pipolo L, and Thomas WG (2001) Association of beta-arrestin 1 with the type 1A angiotensin II receptor involves phosphorylation of the receptor carboxyl terminus and correlates with receptor internalization. Mol Endocrinol 15:1706-1719.
33. Reiter E, Ahn S, Shukla AK, and Lefkowitz RJ (2012) Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors. Annu Rev Pharmacol Toxicol 52:179-197.
34. Sallese M, Mariggiò S, D'Urbano E, Iacovelli L, and De Blasi A (2000) Selective regulation of Gq signaling by G protein-coupled receptor kinase 2: direct interaction of kinase N terminus with activated galphaq. Mol Pharmacol 57:826-831.
35. Saraste J and Goud B (2007) Functional symmetry of endomembranes. Mol Biol Cell 18:1430-1436.
36. Seachrist JL and Ferguson SS (2003) Regulation of G protein-coupled receptor endocytosis and trafficking by Rab GTPases. Life Sci 74:225-235.
37. Seachrist JL, Laporte SA, Dale LB, Babwah AV, Caron MG, Anborgh PH, and Ferguson SS (2002) Rab5 association with the angiotensin II type 1A receptor promotes Rab5 GTP binding and vesicular fusion. J Biol Chem 277:679-685.
38. Soergel DG, Subach RA, Cowan CL, Violin JD, and Lark MW (2013) First clinical experience with TRV027: pharmacokinetics and pharmacodynamics in healthy volunteers. J Clin Pharmacol 53:892-899.
39. Sönnichsen B, De Renzis S, Nielsen E, Rietdorf J, and Zerial M (2000) Distinct membrane domains on endosomes in the recycling pathway visualized by multicolor imaging of Rab4, Rab5, and Rab11. J Cell Biol 149:901-914.
40. Szidonya L, Süpeki K, Karip E, Turu G, Várnai P, Clark AJ, and Hunyady L (2007) AT1 receptor blocker-insensitive mutant AT1A angiotensin receptors reveal the presence of G protein-independent signaling in C9 cells. Biochem Pharmacol 73:1582-1592.
41. Takahashi S, Kubo K, Waguri S, Yabashi A, Shin HW, Katoh Y, and Nakayama K (2012) Rab11 regulates exocytosis of recycling vesicles at the plasma membrane. J Cell Sci 125:4049-4057.
42. Tóth DJ, Tóth JT, Gulyás G, Balla A, Balla T, Hunyady L, and Várnai P (2012) Acute depletion of plasma membrane phosphatidylinositol 4,5-bisphosphate impairs specific steps in endocytosis of the G-protein-coupled receptor. J Cell Sci 125:2185-2197.
43. Turu G, Szidonya L, Gáborik Z, Buday L, Spät A, Clark AJ, and Hunyady L (2006) Differential beta-arrestin binding of AT1 and AT2 angiotensin receptors. FEBS Lett 580:41-45.
44. Várnai P and Balla T (1998) Visualization of phosphoinositides that bind pleckstrin homology domains: calcium- and agonist-induced dynamic changes and relationship to myo-[3H]inositol-labeled phosphoinositide pools. J Cell Biol 143:501-510.
45. Violin JD, Crombie AL, Soergel DG, and Lark MW (2014) Biased ligands at G-protein-coupled receptors: promise and progress. Trends Pharmacol Sci 35:308-316.
46. Violin JD, DeWire SM, Yamashita D, Rominger DH, Nguyen L, Schiller K, Whalen EJ, Gowen M, and Lark MW (2010) Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance. J Pharmacol Exp Ther 335:572-579.
47. Wei H, Ahn S, Shenoy SK, Karnik SS, Hunyady L, Luttrell LM, and Lefkowitz RJ (2003) Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc Natl Acad Sci USA 100:10782-10787.
48. Whalen EJ, Rajagopal S, and Lefkowitz RJ (2011) Therapeutic potential of β-arrestin- and G protein-biased agonists. Trends Mol Med 17:126-139.
49. Woo J and von Arnim AG (2008) Mutational optimization of the coelenterazine-dependent luciferase from Renilla. Plant Methods 4:23.
50. Zerial M and McBride H (2001) Rab proteins as membrane organizers. Nat Rev Mol Cell Biol 2:107-117.
51. Zhang J, Ferguson SS, Barak LS, Ménard L, and Caron MG (1996) Dynamin and beta-arrestin reveal distinct mechanisms for G protein-coupled receptor internalization. J Biol Chem 271:18302-18305.